AbbVie, Principia ally in immunology drug development
AbbVie Inc. and Principia BioPharma Inc. are teaming up to develop oral immunoproteasome inhibitors for immunology indications.
- Drug Discovery Tools
- Includes Contract
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com